ODP is sharing this Health Alert with stakeholders for awareness. For more information, please see ODP Health Alert on levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
This announcement is to announce and distribute the Incident Management Review Guide version 1.0. For more information, please review ODPANN 23-096 and the Incident Management Resource Guide.
Today, the U.S. Department of Health and Human Services (HHS) released an updated joint-policy statement on supporting the inclusion of children with disabilities in early childhood programs. The statement reiterates expectations for
